Indonesian Foreign Policy on Covid-19 Vaccine Procurement
Main Article Content
This study aimed to explain Indonesia's foreign policy on Covid-19 vaccine procurement. It applied foreign policy concepts and qualitative methods to direct, collect, and analyze data. The data were collected through focus group discussions and structured interviews. The results showed that Indonesia's foreign policy on Covid-19 management had a national interest in protecting the public from contracting the virus. The country had 10 vaccines, including Sinovac, AstraZeneca, Pfizer, Moderna, Sinopharm, Johnson & Johnson, Sputnik V, CanSino, Novavax, and Zifivax. The procurement of the Covid-19 vaccine is carried out through bilateral and multilateral channels. The vaccine procurement financing was through buying and grants. The granting countries included China, Japan, the Netherlands, the United States, and the United Arab Emirates; while Covax Facility provided the multilateral grant.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors submitting a manuscript do so on the understanding that if accepted for publication copyright of the article shall be assigned to Intermestic: Journal of International Studies, International Relations Department, Padjadjaran University as the publisher of the journal.